dc.description.abstract | Objective: The aim of this study was to investigate the frequency of posterior femoral cutaneous nerve
(PFCN) lesions in patients referred to the electrophysiology laboratory with an initial diagnosis of sciatic
nerve lesion following injection, and to create awareness that PFCN lesions can occur following
intramuscular injections administered to the gluteal region.
Methods: Fifty-seven patients who were referred to the electrophysiology laboratory because of
injection neuropathy were identified from the hospital records. In addition to the routine electrophysiological
examination, PFCN sensory conduction study was performed according to the technique of
Dumitru and Nelson. The scores of the Hospital Anxiety and Depression Scale (HADS) and the Leeds
Assessment of Neuropathic Symptoms and Signs Pain Scale were recorded for all participants.
Results: Of the 21 participants who agreed to participate in the study, 2 patients were diagnosed with
PFCN lesions, one of them had isolated complete PFCN lesion, and another had it accompanied by
sciatic nerve lesion. Patients with PFCN lesions had a lower body mass index and a higher HADS score
than patients with sciatic nerve lesions (p = 0.01, p = 0.04, respectively)
Conclusions: As correct diagnosis is the priority starting point for successful treatment, clinicians
should plan examinations taking into consideration the fact that PFCN lesions can occur following
gluteal region injection. | tr |